O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-12.53%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.47B
AUM Growth
+$9.47B
(-14%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
41.65%
Holding
145
New
14
Increased
43
Reduced
27
Closed
6
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$95.1M |
| 2 |
Corvus Pharmaceuticals
CRVS
|
$76.2M |
| 3 |
UnitedHealth
UNH
|
$74M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$72.1M |
| 5 |
Eli Lilly
LLY
|
$66.8M |
Top Sells
| 1 |
HNT
HEALTH NET INC
HNT
|
$205M |
| 2 |
Viatris
VTRS
|
$143M |
| 3 |
AFFX
AFFYMETRIX INC
AFFX
|
$75.8M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$56.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
$49.2M |
Sector Composition
| 1 | Healthcare | 90.2% |
| 2 | Financials | 0.22% |
| 3 | Technology | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $487M | 5.13% | 7,624,900 -770,100 | -9% | -$49.2M |
|
2
HCA Healthcare
HCA
$94.5B
| $448M | 4.71% | 5,737,100 -218,500 | -4% | -$17.1M |
|
3
Amgen
AMGN
$155B
| $431M | 4.54% | 2,876,000 -45,000 | -2% | -$6.75M |
|
4
Boston Scientific
BSX
$156B
| $423M | 4.45% | 22,479,700 -1,951,200 | -8% | -$36.7M |
|
5
AbbVie
ABBV
$372B
| $422M | 4.45% | 7,395,700 -52,800 | -0.7% | -$3.02M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $422M | 4.44% | 1,572,715 +148,000 | +10% | +$39.7M |
|
7
Biogen
BIIB
$19.4B
| $397M | 4.18% | 1,526,300 +83,800 | +6% | +$21.8M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $378M | 3.97% | 3,774,077 +108,627 | +3% | +$10.9M |
|
9
Gilead Sciences
GILD
$140B
| $277M | 2.92% | 3,019,200 -402,200 | -12% | -$36.9M |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $260M | 2.74% | 1,870,600 -404,500 | -18% | -$56.3M |
|
|
IPXL
11
DELISTED
Impax Laboratories, Inc.
IPXL
| $217M | 2.28% | 6,776,100 +112,000 | +2% | +$3.59M |
|
12
Thermo Fisher Scientific
TMO
$186B
| $203M | 2.14% | 1,435,000 +55,000 | +4% | +$7.79M |
|
13
Incyte
INCY
$16.5B
| $200M | 2.1% | 2,755,078 -77,900 | -3% | -$5.65M |
|
14
Regeneron Pharmaceuticals
REGN
$61.5B
| $192M | 2.02% | 533,000 +50,000 | +10% | +$18M |
|
|
15
Eli Lilly
LLY
$657B
| $183M | 1.93% | 2,541,300 +928,300 | +58% | +$66.8M |
|
|
WCG
16
DELISTED
Wellcare Health Plans, Inc.
WCG
| $177M | 1.86% | 1,903,300 +557,100 | +41% | +$51.7M |
|
17
Intuitive Surgical
ISRG
$170B
| $166M | 1.75% | 276,800 +37,800 | +16% | +$22.7M |
|
|
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
| $166M | 1.75% | 2,421,000 +239,000 | +11% | +$16.4M |
|
|
19
Vertex Pharmaceuticals
VRTX
$100B
| $149M | 1.56% | 1,869,400 +1,196,400 | +178% | +$95.1M |
|
20
Illumina
ILMN
$15.8B
| $146M | 1.54% | 900,000 +23,000 | +3% | +$3.73M |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $144M | 1.52% | 2,696,000 +250,000 | +10% | +$13.4M |
|
|
ICPT
22
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $144M | 1.51% | 1,120,000 | – | – |
|
23
Agilent Technologies
A
$35.7B
| $139M | 1.47% | 3,495,000 +169,000 | +5% | +$6.73M |
|
|
WMGI
24
DELISTED
Wright Medical Group Inc
WMGI
| $139M | 1.46% | 8,345,110 +99,999 | +1% | +$1.66M |
|
|
MGLN
25
DELISTED
Magellan Health Services, Inc.
MGLN
| $130M | 1.36% | 1,909,000 +76,000 | +4% | +$5.16M |
|